Pathophysiology of IL-33 and IL-17 in allergic disorders
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 38, 22-36
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severityInflammation Research, 2012
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel DiseasesGastroenterology, 2011
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- Transcriptional regulatory networks in Th17 cell differentiationCurrent Opinion in Immunology, 2009
- Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small IntestineCell Host & Microbe, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- The development of allergic inflammationNature, 2008
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007